Home > Healthcare > Medical Devices > Diagnostic Devices > IVD Quality Control Market

IVD Quality Control Market Size

  • Report ID: GMI9695
  • Published Date: Oct 2024
  • Report Format: PDF

IVD Quality Control Market Size

The global IVD quality control market size was valued at USD 1.3 billion in 2023 and is set to register growth at 4.2% CAGR from 2024 to 2032. The growth of this market is primarily driven by the increasing demand for accurate diagnostic testing, advancements in diagnostic technologies, rising demand for point-of-care testing, and stringent regulatory requirements.

 

Another significant growth factor is the rise in healthcare expenditure and improved access to advanced diagnostic tools in emerging markets. As the healthcare industry evolves, the need for precise and reliable diagnostics to guide medical decisions is increasing. This demand directly impacts the need for robust quality control systems to ensure the accuracy and reliability of diagnostic tests. Furthermore, the global prevalence of chronic and infectious diseases has surged, driving the need for continuous and accurate diagnostics. According to the International Diabetes Federation, nearly 537 million adults were diabetic in 2021, highlighting the high disease burden that requires precise diagnostic tools and reliable IVD quality control products.

 

IVD quality control refers to the procedures and measures used to verify the accuracy, precision, and consistency of tests conducted in a controlled laboratory environment (in vitro). These tests are typically performed on biological samples such as blood, urine, or tissue. IVD quality control is crucial for ensuring that diagnostic devices and assays used in clinical laboratories yield reliable results, which are essential for proper diagnosis, treatment, and patient care.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global IVD quality control industry was valued at USD 1.3 billion in 2023 and is set to grow at a 4.2% CAGR from 2024 to 2032, driven by the increasing demand for accurate diagnostic testing.

The quality control segment dominated the market in 2023, accounting for USD 859.6 million, due to its critical role in ensuring the reliability and accuracy of diagnostic tests.

North Americas IVD quality control industry recorded USD 493.2 million in 2023 and is anticipated to reach USD 697.6 million by 2032, largely due to the expanding elderly population with higher diagnostic testing needs.

Key players in the sector include Abbott, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories, Bio-Techne Corporation, Danaher Corporation, F. Hoffmann-La Roche, Helena Laboratories Corporation, Hologic, and Merck.

IVD Quality Control Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 17
  • Tables & Figures: 353
  • Countries covered: 19
  • Pages: 160
 Download Free Sample